For instance, cetuximab, a monoclonal antibody (mAb) that binds to the epidermal growth factor receptor (EGFR), which is typically overexpressed by several cancer types, has been recently developed into a version conjugated to IR700, a photosensitizer that absorbs light at 690 nm. Here, EGFR is linked to cancer.